Sikora, M.; Stec, A.; Chrabaszcz, M.; Waskiel-Burnat, A.; Zaremba, M.; Olszewska, M.; Rudnicka, L.
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis. J. Clin. Med. 2019, 8, 1021.
https://doi.org/10.3390/jcm8071021
AMA Style
Sikora M, Stec A, Chrabaszcz M, Waskiel-Burnat A, Zaremba M, Olszewska M, Rudnicka L.
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis. Journal of Clinical Medicine. 2019; 8(7):1021.
https://doi.org/10.3390/jcm8071021
Chicago/Turabian Style
Sikora, Mariusz, Albert Stec, Magdalena Chrabaszcz, Anna Waskiel-Burnat, Michal Zaremba, Malgorzata Olszewska, and Lidia Rudnicka.
2019. "Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis" Journal of Clinical Medicine 8, no. 7: 1021.
https://doi.org/10.3390/jcm8071021
APA Style
Sikora, M., Stec, A., Chrabaszcz, M., Waskiel-Burnat, A., Zaremba, M., Olszewska, M., & Rudnicka, L.
(2019). Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis. Journal of Clinical Medicine, 8(7), 1021.
https://doi.org/10.3390/jcm8071021